en.unionpedia.org

Asunaprevir, the Glossary

Asunaprevir (formerly BMS-650032, brand name in Japan and Russia Sunvepra) is an experimental drug candidate for the treatment of hepatitis C. It was undergoing development by Bristol-Myers Squibb and has completed Phase III clinical trials in 2013.^[1]

15 relations: Bloomberg L.P., Bristol Myers Squibb, ClinicalTrials.gov, Daclatasvir, Drug development, Enzyme inhibitor, Health Canada, Hepatitis C, Hepatitis C virus, Hepatitis C virus nonstructural protein 3, Japan, Pegylated interferon, Phases of clinical research, Ribavirin, Russia.
Experimental antiviral drugs
NS3/4A protease inhibitors

Bloomberg L.P.

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

See Asunaprevir and Bloomberg L.P.

Bristol Myers Squibb

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company.

See Asunaprevir and Bristol Myers Squibb

ClinicalTrials.gov

ClinicalTrials.gov is a registry of clinical trials.

See Asunaprevir and ClinicalTrials.gov

Daclatasvir

Daclatasvir, sold under the brand name Daklinza, is an antiviral medication used in combination with other medications to treat hepatitis C (HCV). Asunaprevir and Daclatasvir are Carbamates and Pyrrolidines.

See Asunaprevir and Daclatasvir

Drug development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

See Asunaprevir and Drug development

Enzyme inhibitor

An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity.

See Asunaprevir and Enzyme inhibitor

Health Canada

Health Canada (HC; Santé Canada, SC)Health Canada is the applied title under the Federal Identity Program; the legal title is Department of Health.

See Asunaprevir and Health Canada

Hepatitis C

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis.

See Asunaprevir and Hepatitis C

Hepatitis C virus

The hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae.

See Asunaprevir and Hepatitis C virus

Hepatitis C virus nonstructural protein 3

Nonstructural protein 3 (NS3), also known as p-70, is a viral nonstructural protein that is 70 kDa cleavage product of the hepatitis C virus polyprotein.

See Asunaprevir and Hepatitis C virus nonstructural protein 3

Japan

Japan is an island country in East Asia, located in the Pacific Ocean off the northeast coast of the Asian mainland.

See Asunaprevir and Japan

Pegylated interferon

Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012. Asunaprevir and Pegylated interferon are Antiinfective agent stubs.

See Asunaprevir and Pegylated interferon

Phases of clinical research

The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment.

See Asunaprevir and Phases of clinical research